Diabetes News

Non-traumatic amputations – those caused by arterial blockages related to diabetes, smoking, obesity and vascular system complications – are occurring at an alarming rate. Yet physicians may be too quick to amputate as 85 percent of them may be preventable.

The landmark Diabetes Control and Complications Trial showed conclusively that tight blood glucose control significantly reduces the risk of developing complications of diabetes such as eye, kidney and nerve disease. But the DCCT also showed that tight control -- achieved by taking three or more insulin injections daily -- can come at a cost.

Boca Medical Products is initiating a recall of 41 boxes of Closercare Insulin Syringe 29g 1cc product lot number 5JCZ1 as displayed on the inner case and 2320 boxes of Ultilet Insulin Syringe 30g 1/2cc product lot number 5KEO1 as displayed on the inner case.

Heart disease and diabetes are among the most common conditions plaguing Americans today, and they are related to a host of other diseases. Research now also demonstrates that these conditions can be warning signs for some types of digestive cancers.

Researchers have developed a novel technique to deliver insulin genes to the pancreas, the organ that produces the body's insulin. This approach is a major step in the potential treatment of Type I diabetes since patients with the disease do not produce enough insulin on their own.

Serum insulin concentrations provide an imprecise measure of beta cell mass, and no reliable non-invasive measure of beta cell mass has been available, until now.

While cases of premature death and a few other complications have declined, rates of other serious diabetes-related disorders such as heart and eye disease have not improved over the past 25 to 30 years.

An estimated 39,000 U.S. adolescents may have type 2 diabetes and more than 2.5 million may have impaired fasting glucose levels, which could lead to diabetes and other health problems.

The antidepressant sertraline may reduce the risk of recurrent depression and increase the period of time between episodes of depression in patients with diabetes.

A new mechanism for the formation of insulin crystals in the pancreas has been discovered.

Ghrelin, a hormone long considered a key player in obesity, may instead take a major role in maintaining the balance between insulin and glucose and the development of diabetes.

There is currently no evidence available that inhaled insulin (Exubera) in diabetes therapy shows advantages over short-acting human insulin or insulin analogues administered subcutaneously.

IDDM, which used to be referred to as Type 1 diabetes, results from selective destruction of insulin-producing pancreatic islet beta cells by the body's immune system.

A major finding, which represents an important step toward a potential cure for type 1 (insulin-dependent) diabetes, has been made.

Researchers conclude that obesity is a major factor in the recent increase of newly diagnosed diabetes.

Researchers have now carefully crafted a combination therapy that reverses recent-onset type 1 diabetes in 2 models of disease.